APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amlodipine Besylate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Amlodipine Besylate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchAmlodipine Besylate Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Amlodipine Besylate Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Amlodipine Besylate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amlodipine Besylate Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Amlodipine Besylate Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Amlodipine Besylate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Amlodipine Besylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amlodipine Besylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amlodipine Besylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Amlodipine Besylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amlodipine Besylate include Alkem Laboratories, Apotex, Aurobindo Pharma, Cipla, CR Pharmaceutical, Dr. Reddy's Laboratories, Epic Pharma, Hikma Pharmaceuticals and InvaGen Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amlodipine Besylate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amlodipine Besylate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amlodipine Besylate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amlodipine Besylate market size, projected growth trends, production technologies, key applications, and end-use industries.

Amlodipine Besylate Segment by Company

Alkem Laboratories

Apotex

Aurobindo Pharma

Cipla

CR Pharmaceutical

Dr. Reddy's Laboratories

Epic Pharma

Hikma Pharmaceuticals

InvaGen Pharmaceuticals

Lupin Pharmaceuticals

MACLEODS

Oxford Pharm

Strides Pharma

Teva Pharmaceutical

Upsher-Smith Laboratories

Wockhardt

Zydus Pharmaceuticals

Pfizer

Mylan

Sun Pharmaceutical

Amlodipine Besylate Segment by Type

10mg Tablets

2.5mg Tablets

5mg Tablets

Amlodipine Besylate Segment by Application

High Blood Pressure

Heart Disease

Amlodipine Besylate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine Besylate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amlodipine Besylate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine Besylate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amlodipine Besylate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amlodipine Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Amlodipine Besylate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Amlodipine Besylate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Amlodipine Besylate Industry Trends Table 2. Amlodipine Besylate Industry Drivers Table 3. Amlodipine Besylate Industry Opportunities and Challenges Table 4. Amlodipine Besylate Industry Restraints Table 5. Global Amlodipine Besylate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Amlodipine Besylate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Amlodipine Besylate Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Amlodipine Besylate Sales Market Share by Manufacturers Table 9. Global Amlodipine Besylate Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Amlodipine Besylate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Amlodipine Besylate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Amlodipine Besylate Manufacturers, Product Type & Application Table 13. Global Amlodipine Besylate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Amlodipine Besylate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg Tablets Table 17. Major Manufacturers of 2.5mg Tablets Table 18. Major Manufacturers of 5mg Tablets Table 19. Global Amlodipine Besylate Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Amlodipine Besylate Sales by Type (2021-2026) & (W Units) Table 21. Global Amlodipine Besylate Sales by Type (2027-2032) & (W Units) Table 22. Global Amlodipine Besylate Sales Market Share by Type (2021-2026) Table 23. Global Amlodipine Besylate Sales Market Share by Type (2027-2032) Table 24. Global Amlodipine Besylate Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Amlodipine Besylate Revenue by Type (2021-2026) & (W Units) Table 26. Global Amlodipine Besylate Revenue by Type (2027-2032) & (W Units) Table 27. Global Amlodipine Besylate Revenue Market Share by Type (2021-2026) Table 28. Global Amlodipine Besylate Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of High Blood Pressure Table 30. Major Manufacturers of Heart Disease Table 31. Global Amlodipine Besylate Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Amlodipine Besylate Sales by Application (2021-2026) & (W Units) Table 33. Global Amlodipine Besylate Sales by Application (2027-2032) & (W Units) Table 34. Global Amlodipine Besylate Sales Market Share by Application (2021-2026) Table 35. Global Amlodipine Besylate Sales Market Share by Application (2027-2032) Table 36. Global Amlodipine Besylate Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Amlodipine Besylate Revenue by Application (2021-2026) & (W Units) Table 38. Global Amlodipine Besylate Revenue by Application (2027-2032) & (W Units) Table 39. Global Amlodipine Besylate Revenue Market Share by Application (2021-2026) Table 40. Global Amlodipine Besylate Revenue Market Share by Application (2027-2032) Table 41. Global Amlodipine Besylate Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Amlodipine Besylate Sales by Region (2021-2026) & (W Units) Table 43. Global Amlodipine Besylate Sales Market Share by Region (2021-2026) Table 44. Global Amlodipine Besylate Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Amlodipine Besylate Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Amlodipine Besylate Sales by Country (2021-2026) & (W Units) Table 48. North America Amlodipine Besylate Sales by Country (2027-2032) & (W Units) Table 49. Europe Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Amlodipine Besylate Sales by Country (2021-2026) & (W Units) Table 51. Europe Amlodipine Besylate Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Amlodipine Besylate Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Amlodipine Besylate Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Amlodipine Besylate Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Amlodipine Besylate Sales by Country (2027-2032) & (W Units) Table 58. Global Amlodipine Besylate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Amlodipine Besylate Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Amlodipine Besylate Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Amlodipine Besylate Revenue Market Share by Region (2021-2026) Table 62. Global Amlodipine Besylate Revenue Market Share by Region (2027-2032) Table 63. Alkem Laboratories Company Information Table 64. Alkem Laboratories Business Overview Table 65. Alkem Laboratories Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alkem Laboratories Amlodipine Besylate Product Portfolio Table 67. Alkem Laboratories Recent Development Table 68. Apotex Company Information Table 69. Apotex Business Overview Table 70. Apotex Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Apotex Amlodipine Besylate Product Portfolio Table 72. Apotex Recent Development Table 73. Aurobindo Pharma Company Information Table 74. Aurobindo Pharma Business Overview Table 75. Aurobindo Pharma Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Aurobindo Pharma Amlodipine Besylate Product Portfolio Table 77. Aurobindo Pharma Recent Development Table 78. Cipla Company Information Table 79. Cipla Business Overview Table 80. Cipla Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Cipla Amlodipine Besylate Product Portfolio Table 82. Cipla Recent Development Table 83. CR Pharmaceutical Company Information Table 84. CR Pharmaceutical Business Overview Table 85. CR Pharmaceutical Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CR Pharmaceutical Amlodipine Besylate Product Portfolio Table 87. CR Pharmaceutical Recent Development Table 88. Dr. Reddy's Laboratories Company Information Table 89. Dr. Reddy's Laboratories Business Overview Table 90. Dr. Reddy's Laboratories Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio Table 92. Dr. Reddy's Laboratories Recent Development Table 93. Epic Pharma Company Information Table 94. Epic Pharma Business Overview Table 95. Epic Pharma Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Epic Pharma Amlodipine Besylate Product Portfolio Table 97. Epic Pharma Recent Development Table 98. Hikma Pharmaceuticals Company Information Table 99. Hikma Pharmaceuticals Business Overview Table 100. Hikma Pharmaceuticals Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio Table 102. Hikma Pharmaceuticals Recent Development Table 103. InvaGen Pharmaceuticals Company Information Table 104. InvaGen Pharmaceuticals Business Overview Table 105. InvaGen Pharmaceuticals Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio Table 107. InvaGen Pharmaceuticals Recent Development Table 108. Lupin Pharmaceuticals Company Information Table 109. Lupin Pharmaceuticals Business Overview Table 110. Lupin Pharmaceuticals Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio Table 112. Lupin Pharmaceuticals Recent Development Table 113. MACLEODS Company Information Table 114. MACLEODS Business Overview Table 115. MACLEODS Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. MACLEODS Amlodipine Besylate Product Portfolio Table 117. MACLEODS Recent Development Table 118. Oxford Pharm Company Information Table 119. Oxford Pharm Business Overview Table 120. Oxford Pharm Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Oxford Pharm Amlodipine Besylate Product Portfolio Table 122. Oxford Pharm Recent Development Table 123. Strides Pharma Company Information Table 124. Strides Pharma Business Overview Table 125. Strides Pharma Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Strides Pharma Amlodipine Besylate Product Portfolio Table 127. Strides Pharma Recent Development Table 128. Teva Pharmaceutical Company Information Table 129. Teva Pharmaceutical Business Overview Table 130. Teva Pharmaceutical Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Teva Pharmaceutical Amlodipine Besylate Product Portfolio Table 132. Teva Pharmaceutical Recent Development Table 133. Upsher-Smith Laboratories Company Information Table 134. Upsher-Smith Laboratories Business Overview Table 135. Upsher-Smith Laboratories Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio Table 137. Upsher-Smith Laboratories Recent Development Table 138. Wockhardt Company Information Table 139. Wockhardt Business Overview Table 140. Wockhardt Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Wockhardt Amlodipine Besylate Product Portfolio Table 142. Wockhardt Recent Development Table 143. Zydus Pharmaceuticals Company Information Table 144. Zydus Pharmaceuticals Business Overview Table 145. Zydus Pharmaceuticals Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio Table 147. Zydus Pharmaceuticals Recent Development Table 148. Pfizer Company Information Table 149. Pfizer Business Overview Table 150. Pfizer Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Pfizer Amlodipine Besylate Product Portfolio Table 152. Pfizer Recent Development Table 153. Mylan Company Information Table 154. Mylan Business Overview Table 155. Mylan Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Mylan Amlodipine Besylate Product Portfolio Table 157. Mylan Recent Development Table 158. Sun Pharmaceutical Company Information Table 159. Sun Pharmaceutical Business Overview Table 160. Sun Pharmaceutical Amlodipine Besylate Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Sun Pharmaceutical Amlodipine Besylate Product Portfolio Table 162. Sun Pharmaceutical Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Amlodipine Besylate Distributors List Table 166. Amlodipine Besylate Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Amlodipine Besylate Product Image Figure 2. Global Amlodipine Besylate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amlodipine Besylate Market Size (2021-2032) & (US$ Million) Figure 4. Global Amlodipine Besylate Sales (2021-2032) & (W Units) Figure 5. Global Amlodipine Besylate Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Amlodipine Besylate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg Tablets Image Figure 9. 2.5mg Tablets Image Figure 10. 5mg Tablets Image Figure 11. Global Amlodipine Besylate Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Amlodipine Besylate Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Amlodipine Besylate Sales Market Share by Type (2021-2032) Figure 14. Global Amlodipine Besylate Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Amlodipine Besylate Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Amlodipine Besylate Revenue Market Share by Type (2021-2032) Figure 17. High Blood Pressure Image Figure 18. Heart Disease Image Figure 19. Global Amlodipine Besylate Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Amlodipine Besylate Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Amlodipine Besylate Sales Market Share by Application (2021-2032) Figure 22. Global Amlodipine Besylate Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Amlodipine Besylate Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Amlodipine Besylate Revenue Market Share by Application (2021-2032) Figure 25. North America Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Amlodipine Besylate Sales Market Share by Country (2021-2032) Figure 27. U.S. Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Amlodipine Besylate Sales Market Share by Country (2021-2032) Figure 32. Germany Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Amlodipine Besylate Sales Market Share by Country (2021-2032) Figure 39. China Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Amlodipine Besylate Sales Market Share by Country (2021-2032) Figure 47. Brazil Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Amlodipine Besylate Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Amlodipine Besylate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Amlodipine Besylate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Amlodipine Besylate Revenue (2021-2032) & (US$ Million) Figure 58. North America Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Amlodipine Besylate Revenue (2021-2032) & (US$ Million) Figure 60. Europe Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Amlodipine Besylate Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Amlodipine Besylate Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Amlodipine Besylate Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Amlodipine Besylate Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg Tablets
  • 2.5mg Tablets
  • 5mg Tablets
Applications
  • High Blood Pressure
  • Heart Disease
Companies covered
  • Alkem Laboratories
  • Apotex
  • Aurobindo Pharma
  • Cipla
  • CR Pharmaceutical
  • Dr. Reddy's Laboratories
  • Epic Pharma
  • Hikma Pharmaceuticals
  • InvaGen Pharmaceuticals
  • Lupin Pharmaceuticals
  • MACLEODS
  • Oxford Pharm
  • Strides Pharma
  • Teva Pharmaceutical
  • Upsher-Smith Laboratories
  • Wockhardt
  • Zydus Pharmaceuticals
  • Pfizer
  • Mylan
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Amlodipine Besylate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Amlodipine Besylate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Amlodipine Besylate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Amlodipine Besylate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Amlodipine Besylate Market Dynamics
  1. 2.1 Amlodipine Besylate Industry Trends
  2. 2.2 Amlodipine Besylate Industry Drivers
  3. 2.3 Amlodipine Besylate Industry Opportunities and Challenges
  4. 2.4 Amlodipine Besylate Industry Restraints
3 Amlodipine Besylate Market by Manufacturers
  1. 3.1 Global Amlodipine Besylate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Amlodipine Besylate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Amlodipine Besylate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Amlodipine Besylate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amlodipine Besylate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Amlodipine Besylate Manufacturers, Product Type & Application
  7. 3.7 Global Amlodipine Besylate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amlodipine Besylate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amlodipine Besylate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amlodipine Besylate Tier 1, Tier 2, and Tier 3
4 Amlodipine Besylate Market by Type
  1. 4.1 Amlodipine Besylate Type Introduction
  2. 4.1.1 10mg Tablets
  3. 4.1.2 2.5mg Tablets
  4. 4.1.3 5mg Tablets
  5. 4.2 Global Amlodipine Besylate Sales by Type
  6. 4.2.1 Global Amlodipine Besylate Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Amlodipine Besylate Sales by Type (2021-2032)
  8. 4.2.3 Global Amlodipine Besylate Sales Market Share by Type (2021-2032)
  9. 4.3 Global Amlodipine Besylate Revenue by Type
  10. 4.3.1 Global Amlodipine Besylate Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Amlodipine Besylate Revenue by Type (2021-2032)
  12. 4.3.3 Global Amlodipine Besylate Revenue Market Share by Type (2021-2032)
5 Amlodipine Besylate Market by Application
  1. 5.1 Amlodipine Besylate Application Introduction
  2. 5.1.1 High Blood Pressure
  3. 5.1.2 Heart Disease
  4. 5.2 Global Amlodipine Besylate Sales by Application
  5. 5.2.1 Global Amlodipine Besylate Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Amlodipine Besylate Sales by Application (2021-2032)
  7. 5.2.3 Global Amlodipine Besylate Sales Market Share by Application (2021-2032)
  8. 5.3 Global Amlodipine Besylate Revenue by Application
  9. 5.3.1 Global Amlodipine Besylate Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Amlodipine Besylate Revenue by Application (2021-2032)
  11. 5.3.3 Global Amlodipine Besylate Revenue Market Share by Application (2021-2032)
6 Global Amlodipine Besylate Sales by Region
  1. 6.1 Global Amlodipine Besylate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amlodipine Besylate Sales by Region (2021-2032)
  3. 6.2.1 Global Amlodipine Besylate Sales by Region (2021-2026)
  4. 6.2.2 Global Amlodipine Besylate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Amlodipine Besylate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Amlodipine Besylate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Amlodipine Besylate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Amlodipine Besylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Amlodipine Besylate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Amlodipine Besylate Revenue by Region
  1. 7.1 Global Amlodipine Besylate Revenue by Region
  2. 7.1.1 Global Amlodipine Besylate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Amlodipine Besylate Revenue by Region (2021-2026)
  4. 7.1.3 Global Amlodipine Besylate Revenue by Region (2027-2032)
  5. 7.1.4 Global Amlodipine Besylate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Amlodipine Besylate Revenue (2021-2032)
  8. 7.2.2 North America Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Amlodipine Besylate Revenue (2021-2032)
  11. 7.3.2 Europe Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Amlodipine Besylate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Amlodipine Besylate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Amlodipine Besylate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alkem Laboratories
  2. 8.1.1 Alkem Laboratories Company Information
  3. 8.1.2 Alkem Laboratories Business Overview
  4. 8.1.3 Alkem Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alkem Laboratories Amlodipine Besylate Product Portfolio
  6. 8.1.5 Alkem Laboratories Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Amlodipine Besylate Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 Aurobindo Pharma
  14. 8.3.1 Aurobindo Pharma Company Information
  15. 8.3.2 Aurobindo Pharma Business Overview
  16. 8.3.3 Aurobindo Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aurobindo Pharma Amlodipine Besylate Product Portfolio
  18. 8.3.5 Aurobindo Pharma Recent Developments
  19. 8.4 Cipla
  20. 8.4.1 Cipla Company Information
  21. 8.4.2 Cipla Business Overview
  22. 8.4.3 Cipla Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cipla Amlodipine Besylate Product Portfolio
  24. 8.4.5 Cipla Recent Developments
  25. 8.5 CR Pharmaceutical
  26. 8.5.1 CR Pharmaceutical Company Information
  27. 8.5.2 CR Pharmaceutical Business Overview
  28. 8.5.3 CR Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CR Pharmaceutical Amlodipine Besylate Product Portfolio
  30. 8.5.5 CR Pharmaceutical Recent Developments
  31. 8.6 Dr. Reddy's Laboratories
  32. 8.6.1 Dr. Reddy's Laboratories Company Information
  33. 8.6.2 Dr. Reddy's Laboratories Business Overview
  34. 8.6.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
  36. 8.6.5 Dr. Reddy's Laboratories Recent Developments
  37. 8.7 Epic Pharma
  38. 8.7.1 Epic Pharma Company Information
  39. 8.7.2 Epic Pharma Business Overview
  40. 8.7.3 Epic Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Epic Pharma Amlodipine Besylate Product Portfolio
  42. 8.7.5 Epic Pharma Recent Developments
  43. 8.8 Hikma Pharmaceuticals
  44. 8.8.1 Hikma Pharmaceuticals Company Information
  45. 8.8.2 Hikma Pharmaceuticals Business Overview
  46. 8.8.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
  48. 8.8.5 Hikma Pharmaceuticals Recent Developments
  49. 8.9 InvaGen Pharmaceuticals
  50. 8.9.1 InvaGen Pharmaceuticals Company Information
  51. 8.9.2 InvaGen Pharmaceuticals Business Overview
  52. 8.9.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
  54. 8.9.5 InvaGen Pharmaceuticals Recent Developments
  55. 8.10 Lupin Pharmaceuticals
  56. 8.10.1 Lupin Pharmaceuticals Company Information
  57. 8.10.2 Lupin Pharmaceuticals Business Overview
  58. 8.10.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
  60. 8.10.5 Lupin Pharmaceuticals Recent Developments
  61. 8.11 MACLEODS
  62. 8.11.1 MACLEODS Company Information
  63. 8.11.2 MACLEODS Business Overview
  64. 8.11.3 MACLEODS Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MACLEODS Amlodipine Besylate Product Portfolio
  66. 8.11.5 MACLEODS Recent Developments
  67. 8.12 Oxford Pharm
  68. 8.12.1 Oxford Pharm Company Information
  69. 8.12.2 Oxford Pharm Business Overview
  70. 8.12.3 Oxford Pharm Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Oxford Pharm Amlodipine Besylate Product Portfolio
  72. 8.12.5 Oxford Pharm Recent Developments
  73. 8.13 Strides Pharma
  74. 8.13.1 Strides Pharma Company Information
  75. 8.13.2 Strides Pharma Business Overview
  76. 8.13.3 Strides Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Strides Pharma Amlodipine Besylate Product Portfolio
  78. 8.13.5 Strides Pharma Recent Developments
  79. 8.14 Teva Pharmaceutical
  80. 8.14.1 Teva Pharmaceutical Company Information
  81. 8.14.2 Teva Pharmaceutical Business Overview
  82. 8.14.3 Teva Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Teva Pharmaceutical Amlodipine Besylate Product Portfolio
  84. 8.14.5 Teva Pharmaceutical Recent Developments
  85. 8.15 Upsher-Smith Laboratories
  86. 8.15.1 Upsher-Smith Laboratories Company Information
  87. 8.15.2 Upsher-Smith Laboratories Business Overview
  88. 8.15.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
  90. 8.15.5 Upsher-Smith Laboratories Recent Developments
  91. 8.16 Wockhardt
  92. 8.16.1 Wockhardt Company Information
  93. 8.16.2 Wockhardt Business Overview
  94. 8.16.3 Wockhardt Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Wockhardt Amlodipine Besylate Product Portfolio
  96. 8.16.5 Wockhardt Recent Developments
  97. 8.17 Zydus Pharmaceuticals
  98. 8.17.1 Zydus Pharmaceuticals Company Information
  99. 8.17.2 Zydus Pharmaceuticals Business Overview
  100. 8.17.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
  102. 8.17.5 Zydus Pharmaceuticals Recent Developments
  103. 8.18 Pfizer
  104. 8.18.1 Pfizer Company Information
  105. 8.18.2 Pfizer Business Overview
  106. 8.18.3 Pfizer Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Pfizer Amlodipine Besylate Product Portfolio
  108. 8.18.5 Pfizer Recent Developments
  109. 8.19 Mylan
  110. 8.19.1 Mylan Company Information
  111. 8.19.2 Mylan Business Overview
  112. 8.19.3 Mylan Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Mylan Amlodipine Besylate Product Portfolio
  114. 8.19.5 Mylan Recent Developments
  115. 8.20 Sun Pharmaceutical
  116. 8.20.1 Sun Pharmaceutical Company Information
  117. 8.20.2 Sun Pharmaceutical Business Overview
  118. 8.20.3 Sun Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Sun Pharmaceutical Amlodipine Besylate Product Portfolio
  120. 8.20.5 Sun Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amlodipine Besylate Value Chain Analysis
  2. 9.1.1 Amlodipine Besylate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amlodipine Besylate Production Mode & Process
  6. 9.2 Amlodipine Besylate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amlodipine Besylate Distributors
  9. 9.2.3 Amlodipine Besylate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst